Cargando…
Barriers and Facilitators to the Implementation of Personalised Medicine across Europe
(1) Background: Personalised medicine (PM) is an innovative way to produce better patient outcomes by using an individualised or stratified approach to disease and treatment rather than a collective approach to treating patients. PM is a major challenge for all European healthcare systems. This arti...
Autores principales: | Stefanicka-Wojtas, Dorota, Kurpas, Donata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965772/ https://www.ncbi.nlm.nih.gov/pubmed/36836438 http://dx.doi.org/10.3390/jpm13020203 |
Ejemplares similares
-
Personalised Medicine—Implementation to the Healthcare System in Europe (Focus Group Discussions)
por: Stefanicka-Wojtas, Dorota, et al.
Publicado: (2023) -
eHealth and mHealth in Chronic Diseases—Identification of Barriers, Existing Solutions, and Promoters Based on a Survey of EU Stakeholders Involved in Regions4PerMed (H2020)
por: Stefanicka-Wojtas, Dorota, et al.
Publicado: (2022) -
The Advantages and Disadvantages of Integrated Care Implementation in Central and Eastern Europe – Perspective from 9 CEE Countries
por: Kurpas, Donata, et al.
Publicado: (2021) -
Challenges in Implementing Integrated Care in Central and Eastern Europe – Experience of Poland
por: Kurpas, Donata
Publicado: (2020) -
Barriers and Facilitators in the Implementation of Prevention Strategies for Chronic Disease Patients—Best Practice GuideLines and Policies’ Systematic Review
por: Duda-Sikuła, Marta, et al.
Publicado: (2023)